It has been found and characterized that GSCs-derived TFPI2 can regulate the maintenance of tumor stem cell stemness and the migration and immunosuppression of microglia in the tumor microenvironment through different mechanisms, respectively (Pang et al., 2023). The gene discussed is TFPI2; the disease is neoplasm.